Row lingers for UK genetic testing company
This article was originally published in Clinica
DNA Bioscience, the UK genetic testing company which this week became embroiled in a row over the fact that one of its former directors was a UK government minister whose department was in discussions with it over future supply contracts, is now facing questions over its accreditation status, Clinica has learnt.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.